0001214659-21-005926.txt : 20210526
0001214659-21-005926.hdr.sgml : 20210526
20210526080015
ACCESSION NUMBER: 0001214659-21-005926
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210524
FILED AS OF DATE: 20210526
DATE AS OF CHANGE: 20210526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHMIDT ERIC THOMAS
CENTRAL INDEX KEY: 0001754403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 21962755
MAIL ADDRESS:
STREET 1: C/O ALLOGENE THERAPEUTICS, INC.
STREET 2: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-52930.xml
PRIMARY DOCUMENT
X0306
4
2021-05-24
0001737287
Allogene Therapeutics, Inc.
ALLO
0001754403
SCHMIDT ERIC THOMAS
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Financial Officer
Common Stock
2021-05-24
4
M
false
14897
18.22
A
110994
D
Common Stock
1152595
I
See footnote
Stock Option (Right to Buy)
18.22
2021-05-24
4
M
false
14897
0.00
D
2030-03-18
Common Stock
14897
94703
D
The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.
/s/ Veer Bhavnagri, Attorney-in-Fact
2021-05-24